Last reviewed · How we verify
administration of UIC202205, UIC202206 — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
administration of UIC202205, UIC202206 (administration of UIC202205, UIC202206) — Korea United Pharm. Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| administration of UIC202205, UIC202206 TARGET | administration of UIC202205, UIC202206 | Korea United Pharm. Inc. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- administration of UIC202205, UIC202206 CI watch — RSS
- administration of UIC202205, UIC202206 CI watch — Atom
- administration of UIC202205, UIC202206 CI watch — JSON
- administration of UIC202205, UIC202206 alone — RSS
Cite this brief
Drug Landscape (2026). administration of UIC202205, UIC202206 — Competitive Intelligence Brief. https://druglandscape.com/ci/administration-of-uic202205-uic202206. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab